Ulcerative Colitis
Ulcerative Colitis is a chronic inflammatory condition of the colon characterized by inflammation and ulceration of the intestinal lining, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding.
Ulcerative Colitis: SAR443122 Study
We are testing different doses of SAR443122 in adults with moderate to severe ulcerative colitis to see how well it works and its safety. The study will also look at improvements in symptoms and quality of life.
1-2 years6-10 visitsEfficacy phase (II)Post-Trial Drug AccessPartially RemoteStandard MedicinesOralGastroenterologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have Ulcerative Colitis (UC) that has been active for at least 3 months?
- Are you currently taking corticosteroids like Prednisone or Dexamethasone?
- Are you pregnant or breastfeeding?
- Have you had any live vaccines in the last 3 months?
- Do you have uncontrolled diabetes, defined as an HbA1c level of 9.0% or higher?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Multispecialty hospital for active treatment Sveta Sofia EOOD
Gastroenterology
Sofia, Bulgaria
Iscare a.s.
site 003_Klinicke a vyzkumne centrum pro strevni zanety
Čakovice, Czechia
MEDIC KRAL s.r.o.
site 004_Gastroenterologická ordinace
Čakovice, Czechia
Sponsor: Sanofi-Aventis Research & Development
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.